CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+31.63%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$1.58B
(+17%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
7.44%
Top 10 Holdings %
Top 10 Hldgs %
72.95%
Holding
32
New
8
Increased
10
Reduced
2
Closed
6
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$80.6M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
$43.2M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$43.1M |
| 4 |
Omeros
OMER
|
$36.9M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$32M |
Top Sells
| 1 |
Exelixis
EXEL
|
$131M |
| 2 |
LMNX
Luminex Corp
LMNX
|
$55.5M |
| 3 |
Corcept Therapeutics
CORT
|
$28.9M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$26M |
| 5 |
Pacific Biosciences
PACB
|
$18.2M |
Sector Composition
| 1 | Healthcare | 92.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $228M | 14.4% | 10,990,975 +1,540,212 | +16% | +$32M |
|
2
United Therapeutics
UTHR
$13.8B
| $144M | 9.08% | 1,225,387 +124,790 | +11% | +$14.6M |
|
3
Pacira BioSciences
PCRX
$1.2B
| $139M | 8.77% | 3,652,134 | – | – |
|
4
uniQure
QURE
$896M
| $118M | 7.48% | 1,985,460 +89,234 | +5% | +$5.32M |
|
5
Myriad Genetics
MYGN
$593M
| $110M | 6.94% | 3,309,206 +938,910 | +40% | +$31.2M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $91.2M | 5.76% | 4,032,123 | – | – |
|
|
7
Catalyst Pharmaceutical
CPRX
$2.52B
| $91.2M | 5.75% | 17,875,655 +8,473,338 | +90% | +$43.2M |
|
|
AERI
8
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $80.6M | 5.09% | +1,696,773 | New | +$80.6M |
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $78.4M | 4.95% | 4,258,358 -400,401 | -9% | -$7.37M |
|
10
Vericel Corp
VCEL
$1.83B
| $75.1M | 4.74% | 4,288,092 +70,000 | +2% | +$1.23M |
|
11
UroGen Pharma
URGN
$900M
| $65M | 4.1% | 1,759,324 +243,902 | +16% | +$9.01M |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $44.9M | 2.84% | 2,608,784 +29,000 | +1% | +$500K |
|
|
13
Corcept Therapeutics
CORT
$7.35B
| $44M | 2.78% | 3,747,453 -2,464,511 | -40% | -$28.9M |
|
|
EPZM
14
DELISTED
Epizyme, Inc
EPZM
| $43.1M | 2.72% | +3,478,261 | New | +$43.1M |
|
|
15
Omeros
OMER
$283M
| $36.9M | 2.33% | +2,124,619 | New | +$36.9M |
|
|
KDMN
16
DELISTED
Kadmon Holdings, Inc.
KDMN
| $30.7M | 1.94% | +11,627,900 | New | +$30.7M |
|
17
Karyopharm Therapeutics
KPTI
$61.7M
| $30.1M | 1.9% | 5,158,884 +348,806 | +7% | +$2.04M |
|
18
Aurinia Pharmaceuticals
AUPH
$1.58B
| $27.4M | 1.73% | 4,222,558 +4,212,558 | +42,126% | +$27.4M |
|
|
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
| $23.2M | 1.46% | +1,666,667 | New | +$23.2M |
|
20
Savara
SVRA
$567M
| $22.8M | 1.44% | 3,093,690 | – | – |
|
21
ADMA Biologics
ADMA
$4.12B
| $17.4M | 1.1% | 4,588,352 | – | – |
|
22
Akebia Therapeutics
AKBA
$833M
| $11.7M | 0.74% | +1,430,579 | New | +$11.7M |
|
23
Iovance Biotherapeutics
IOVA
$807M
| $10.8M | 0.68% | +1,140,000 | New | +$10.8M |
|
24
ANI Pharmaceuticals
ANIP
$2.03B
| $10.1M | 0.64% | 142,943 | – | – |
|
|
IMMU
25
DELISTED
Immunomedics Inc
IMMU
| $2.79M | 0.18% | +145,000 | New | +$2.79M |
|